Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)Kathrin Heinrich, Dominik Paul Modest, Ludwig Fischer von Weikersthal et al.|ESMO Open|2023Cited by 10
Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).Dominik Paul Modest, Tanja Trarbach, Meinolf Karthaus et al.|Journal of Clinical Oncology|2021Cited by 6
Impact of age and gender on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC): Subgroup analysis of the PANAMA-study (AIO-KRK-0212).Kathrin Heinrich, Dominik Paul Modest, Meinolf Karthaus et al.|Journal of Clinical Oncology|2022Cited by 0